EMHTF News and Press, Emerald Health Therapeutics From 11/29/21

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") today announced that it is exiting the recreational and medical cannabis business and pivoting to a pharmaceutical development focus. Eme...

Emerald Health Therapeutics (OTCQX:EMHTF) and HYTN Cannabis have signed a definitive agreement to co-launch, sell and distribute HYTN's proprietary new sparkling cannabis beverages across Canada. The partnership will leverage Emerald's established cannabis sales license, sales team ...

Emerald partners with HYTN to sell and distribute HYTN's calorie-free, fast-acting THC-infused sparkling cannabis beverages as new alternative in the rapidly growing cannabis beverage market Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (...

Emerald Patent Licensee Announces Partnership with Leading Cannabis Vaporization Technology Company, Grenco Science Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that its partner, FlowerPod ...

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepburn, will be stepping down from her position at Emerald, effective October 15, 2021, to pursue...

Emerald Health Therapeutics, Inc. (EMHTF) Q2 2021 Earnings Conference Call August 31, 2021, 10:30 AM ET Company Participants Bernie Hertel - VP, Finance and Communications Riaz Bandali - President and Chief Executive Officer Moe Jiwan - Chief Operating Officer Jenn Hepburn - Chief Financial O...

Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) reported its financial results for the second quarter ending June 30, 2021, with total sales of C$3.7 million, which increased over the first quarter’s C$2.6 million. The net losses for Emerald Health increased...

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")  has released its financial results for the three and six months ended June 30, 2021. Full versions of Emerald's unaudited condensed interim consolidat...

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Monday, August 30,...

Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) -  Further to its press release of August 6 th , Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") provides additional details regarding the resignation of Dr. Avtar Dhillon as director ...